165 related articles for article (PubMed ID: 22318658)
1. A histopathological diagnostic marker for human spinal astrocytoma: expression of glial fibrillary acidic protein-δ.
Heo DH; Kim SH; Yang KM; Cho YJ; Kim KN; Yoon DH; Kang TC
J Neurooncol; 2012 May; 108(1):45-52. PubMed ID: 22318658
[TBL] [Abstract][Full Text] [Related]
2. Enhanced glial fibrillary acidic protein-delta expression in human astrocytic tumor.
Choi KC; Kwak SE; Kim JE; Sheen SH; Kang TC
Neurosci Lett; 2009 Oct; 463(3):182-7. PubMed ID: 19647039
[TBL] [Abstract][Full Text] [Related]
3. The molecular characteristics of spinal cord gliomas with or without H3 K27M mutation.
Chai RC; Zhang YW; Liu YQ; Chang YZ; Pang B; Jiang T; Jia WQ; Wang YZ
Acta Neuropathol Commun; 2020 Mar; 8(1):40. PubMed ID: 32228694
[TBL] [Abstract][Full Text] [Related]
4. Could changes in the regulation of the PI3K/PKB/Akt signaling pathway and cell cycle be involved in astrocytic tumor pathogenesis and progression?
Hlobilkova A; Ehrmann J; Sedlakova E; Krejci V; Knizetova P; Fiuraskova M; Kala M; Kalita O; Kolar Z
Neoplasma; 2007; 54(4):334-41. PubMed ID: 17822324
[TBL] [Abstract][Full Text] [Related]
5. Aberrant localization of the neuronal class III beta-tubulin in astrocytomas.
Katsetos CD; Del Valle L; Geddes JF; Assimakopoulou M; Legido A; Boyd JC; Balin B; Parikh NA; Maraziotis T; de Chadarevian JP; Varakis JN; Matsas R; Spano A; Frankfurter A; Herman MM; Khalili K
Arch Pathol Lab Med; 2001 May; 125(5):613-24. PubMed ID: 11300931
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical analysis of GFAP-δ and nestin in cerebral astrocytomas.
Brehar FM; Arsene D; Brinduse LA; Gorgan MR
Brain Tumor Pathol; 2015 Apr; 32(2):90-8. PubMed ID: 25178519
[TBL] [Abstract][Full Text] [Related]
7. Combined molecular analysis of BRAF and IDH1 distinguishes pilocytic astrocytoma from diffuse astrocytoma.
Korshunov A; Meyer J; Capper D; Christians A; Remke M; Witt H; Pfister S; von Deimling A; Hartmann C
Acta Neuropathol; 2009 Sep; 118(3):401-5. PubMed ID: 19543740
[TBL] [Abstract][Full Text] [Related]
8. BRAF alterations are frequent in cerebellar low-grade astrocytomas with diffuse growth pattern.
Ida CM; Lambert SR; Rodriguez FJ; Voss JS; Mc Cann BE; Seys AR; Halling KC; Collins VP; Giannini C
J Neuropathol Exp Neurol; 2012 Jul; 71(7):631-9. PubMed ID: 22710963
[TBL] [Abstract][Full Text] [Related]
9. An immunocytochemical comparison of glial fibrillary acidic protein, S-100p and vimentin in human glial tumors.
Nakopoulou L; Kerezoudi E; Thomaides T; Litsios B
J Neurooncol; 1990 Feb; 8(1):33-40. PubMed ID: 2319288
[TBL] [Abstract][Full Text] [Related]
10. Expression patterns of glial fibrillary acidic protein (GFAP)-delta in epilepsy-associated lesional pathologies.
Martinian L; Boer K; Middeldorp J; Hol EM; Sisodiya SM; Squier W; Aronica E; Thom M
Neuropathol Appl Neurobiol; 2009 Aug; 35(4):394-405. PubMed ID: 19508443
[TBL] [Abstract][Full Text] [Related]
11. Morphometrical analysis of GFAP-positive cells in human astrocytomas.
Yoshii Y; Narushima K; Tsurushima H; Yanaka K; Hyodo A; Nose T; Sugiyama K; Sakamura S
Neurol Med Chir (Tokyo); 1992 Jul; 32(8):554-8. PubMed ID: 1383844
[TBL] [Abstract][Full Text] [Related]
12. J1-31 protein expression in astrocytes and astrocytomas.
Shuangshoti S; Thorner PS; Ruangvejvorachai P; Saha B; Groshen S; Taylor CR; Malhotra S; Imam SA
Neuropathology; 2009 Oct; 29(5):521-7. PubMed ID: 19019178
[TBL] [Abstract][Full Text] [Related]
13. Astrocytoma grade IV (glioblastoma multiforme) displays 3 subtypes with unique expression profiles of intermediate filament proteins.
Skalli O; Wilhelmsson U; Orndahl C; Fekete B; Malmgren K; Rydenhag B; Pekny M
Hum Pathol; 2013 Oct; 44(10):2081-8. PubMed ID: 23791210
[TBL] [Abstract][Full Text] [Related]
14. Expression of neuronal markers, NFP and GFAP, in malignant astrocytoma.
Hashemi F; Naderian M; Kadivar M; Nilipour Y; Gheytanchi E
Asian Pac J Cancer Prev; 2014; 15(15):6315-9. PubMed ID: 25124617
[TBL] [Abstract][Full Text] [Related]
15. Pathologic analysis of primary brain tumors.
McComb RD; Burger PC
Neurol Clin; 1985 Nov; 3(4):711-28. PubMed ID: 3001488
[TBL] [Abstract][Full Text] [Related]
16. Correlation of glial fibrillary acidic protein (GFAP) with grading of the neuroglial tumours.
Reyaz N; Tayyab M; Khan SA; Siddique T
J Coll Physicians Surg Pak; 2005 Aug; 15(8):472-5. PubMed ID: 16202357
[TBL] [Abstract][Full Text] [Related]
17. Importance of GFAP isoform-specific analyses in astrocytoma.
van Bodegraven EJ; van Asperen JV; Robe PAJ; Hol EM
Glia; 2019 Aug; 67(8):1417-1433. PubMed ID: 30667110
[TBL] [Abstract][Full Text] [Related]
18. Astrocyte-specific expression of activated p21-ras results in malignant astrocytoma formation in a transgenic mouse model of human gliomas.
Ding H; Roncari L; Shannon P; Wu X; Lau N; Karaskova J; Gutmann DH; Squire JA; Nagy A; Guha A
Cancer Res; 2001 May; 61(9):3826-36. PubMed ID: 11325859
[TBL] [Abstract][Full Text] [Related]
19. Expression of fascin, an actin-bundling protein, in astrocytomas of varying grades.
Peraud A; Mondal S; Hawkins C; Mastronardi M; Bailey K; Rutka JT
Brain Tumor Pathol; 2003; 20(2):53-8. PubMed ID: 14756441
[TBL] [Abstract][Full Text] [Related]
20. The role of FilGAP, a Rac-specific Rho-GTPase-activating protein, in tumor progression and behavior of astrocytomas.
Hara A; Hashimura M; Tsutsumi K; Akiya M; Inukai M; Ohta Y; Saegusa M
Cancer Med; 2016 Dec; 5(12):3412-3425. PubMed ID: 27790861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
